1. bookVolume 22 (2014): Edition 1 (March 2014)
Détails du magazine
License
Format
Magazine
eISSN
2284-5623
ISSN
2284-5623
Première parution
08 Aug 2013
Périodicité
4 fois par an
Langues
Anglais
access type Accès libre

Venous thromboembolism caused by testosterone abuse in a young man with previously undiagnosed genetic thrombophilia

Publié en ligne: 25 Mar 2014
Volume & Edition: Volume 22 (2014) - Edition 1 (March 2014)
Pages: 63 - 68
Détails du magazine
License
Format
Magazine
eISSN
2284-5623
ISSN
2284-5623
Première parution
08 Aug 2013
Périodicité
4 fois par an
Langues
Anglais
Abstract

Venous thromboembolism (VTE) is a multifactorial disease; age, a prior history of deep vein thrombosis, cancer, surgery, obesity, prolonged immobility, pregnancy, oral contraceptive agents, thrombophilia, have been identified as major risk factors. Thrombophilia is a heritable or acquired prothrombotic state that increases the tendency to venous thromboembolism. The use of anabolic steroids is strongly linked to venous thromboembolism, due to their role in thrombus formation. We present a case of a venous thromboembolism in a 26-year old male who had undergone a testosterone abuse and had a previously undiagnosed genetic thrombophilia, with discussion upon literature regarding the heritable thrombophilia and prothrombotic effects of testosterone.

Keywords

Cuvinte cheie

1. Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008 Mar 6;358(10):1037-52. DOI: 10.1056/NEJMra07275310.1056/NEJMra072753Search in Google Scholar

2. National Clinical Guideline Centre (UK). Venous Thromboembolic Diseases: The Management of Venous Thromboembolic Diseases and the Role of Thrombophilia Testing [Internet]. London: Royal College of Physicians (UK); 2012 Jun. http://www.ncbi.nlm.nih.gov/books/NBK132796/Search in Google Scholar

3. Dickerman RD, McConathy WJ, Schaller F, Zachariah NY. Cardiovascular complications and anabolic steroids. Eur Heart J. 1996 Dec;17(12):1912.10.1093/oxfordjournals.eurheartj.a014812Search in Google Scholar

4. Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, et al.; FITENAT Study Group. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution. Blood Coagul Fibrinolysis. 2009 Oct;20(7):503-10. DOI: 10.1097/ MBC.0b013e32832f5d7a10.1097/MBC.0b013e32832f5d7aSearch in Google Scholar

5. Bienvenu T, Ankri A, Chadefaux B, Montalescot G, Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters, Thrombosis Research, 1993 April;70(2):123-25. DOI: 10.1016/0049-3848(93)90153-F10.1016/0049-3848(93)90153-FSearch in Google Scholar

6. Spiroski I, Kedev S, Antov S, Arsov T, Krstevska M, Dzhekova-Stojkova S, et al. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis. Acta Biochim Pol. 2008;55(3):587-94. Epub 2008 Sep 18.10.18388/abp.2008_3065Search in Google Scholar

7. Quéré I, Chassé JF, Dupuy E, Bellet E, Molho-Sabatier P, Tobelem G, et al. Homocysteine, 5,10-methylenetetrahydrofolate reductase and deep venous thrombosis. Survey of 120 patients in internal medicine. Rev Med Interne. 1998 Jan;19(1):29-33. DOI: 10.1016/S0248-8663(97)83696-X10.1016/S0248-8663(97)83696-XSearch in Google Scholar

8. Simone B, Stefano VD, Leoncini E, Zacho J, Martinelli I, Emmerich J, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013 Aug 1;28(8):621-47. DOI: 10.1007/s10654-013-9825-810.1007/s10654-013-9825-8393523723900608Search in Google Scholar

9. Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genet Med. 2013 Feb;15(2):153-6. DOI: 10.1038/gim.2012.16510.1038/gim.2012.16523288205Search in Google Scholar

10. De Stefano V, Rossi E. Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups. Thromb Haemost. 2013 Oct;110(4):697-705. DOI: 10.1160/TH13-01-001110.1160/TH13-01-001123846575Search in Google Scholar

11. Ilhan E, Demirci D, Güvenç TS, Calık AN. Acute myocardial infarction and renal infarction in a bodybuilder using anabolic steroids. Turk Kardiyol Dern Ars. 2010 Jun;38(4):275-8.Search in Google Scholar

12. Choi BG, McLaughlin MA. Why men’s hearts break: cardiovascular effects of sex steroids. Endocrinol Metab Clin North Am. 2007 Jun;36(2):365-77. DOI: 10.1016/j.ecl.2007.03.01110.1016/j.ecl.2007.03.01117543724Search in Google Scholar

13. Glueck CJ, Goldenberg N, Budhani S, Lotner D, Abuchaibe C, Gowda M.et al. Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia. Transl Res. 2011 Oct;158(4):225-34. DOI: 10.1016/j.trsl.2011.06.00310.1016/j.trsl.2011.06.00321925119Search in Google Scholar

14. Glueck CJ, Richardson-Royer C, Schultz R, Burger T, Labitue F, Riaz MK, et al. Testosterone, ThrombophilSearch in Google Scholar

Articles recommandés par Trend MD

Planifiez votre conférence à distance avec Sciendo